Logo image
Ethical Considerations for Artificial Intelligence in Medical Imaging:Deployment and Governance
Journal article   Open access   Peer reviewed

Ethical Considerations for Artificial Intelligence in Medical Imaging:Deployment and Governance

Jonathan Herington, Melissa D McCradden, Kathleen Creel, Ronald Boellaard, Elizabeth C Jones, Abhinav K Jha, Arman Rahmim, Peter J. H Scott, John J Sunderland, Richard L Wahl, …
The Journal of nuclear medicine : JNM, Vol.64(10), pp.1509-1515
10/01/2023
DOI: 10.2967/jnumed.123.266110
PMCID: PMC12782051
PMID: 37620051
url
https://doi.org/10.2967/jnumed.123.266110View
Published (Version of record) Open Access

Abstract

The deployment of artificial intelligence (AI) has the potential to make nuclear medicine and medical imaging faster, cheaper, and both more effective and more accessible. This is possible, however, only if clinicians and patients feel that these AI medical devices (AIMDs) are trustworthy. Highlighting the need to ensure health justice by fairly distributing benefits and burdens while respecting individual patients’ rights, the AI Task Force of the Society of Nuclear Medicine and Molecular Imaging has identified 4 major ethical risks that arise during the deployment of AIMD: autonomy of patients and clinicians, transparency of clinical performance and limitations, fairness toward marginalized populations, and accountability of physicians and developers. We provide preliminary recommendations for governing these ethical risks to realize the promise of AIMD for patients and populations.
AI ethics software as medical device fairness explain ability justice

Details

Metrics

Logo image